Search results for

As the Trump administration decides not to defend the Affordable Care Act's legal protections for people with pre-existing conditions, questions arise about health insurance and genetic information.

Amnesty International USA is demanding an investigation into what it says is a lackluster response by Justice Department officials to the 6,000-page Senate torture report released in 2014.

DOJ veterans and lawmakers are warning the Trump administration about breaching the agency's autonomy. They cite a pattern of contacts between the White House and the Justice Department this year.

Food and Drug Commissioner Scott Gottlieb says he wants to know why drugmakers churn out medicines for some rare diseases but not others.

In his new book, Pablo Yanguas argues that fudged numbers, shallow aid projects and politics have created a dysfunctional aid system.

In Jennifer Mathieu's novel, "nice girl" Vivian secretly publishes a zine decrying her high school's culture of sexist harassment. Our reviewer says Moxie works on a "pure, wish-fulfillment level."

The 85-year-old novelist worked for MI5 and MI6 early in his career. "I felt I had to suppress my humanity," he says of those years. His new novel is called A Legacy of Spies.

The president pardoned Arizona Sheriff Joe Arpaio, has teased that he could pardon others and this week, the week of Thanksgiving, he will again.

Is geography destiny? It goes against the core idea of the American dream, but a new online data tool says where you were born and raised actually makes a huge difference — down to the very block.

Ed Piskor is back with another volume of his popular Hip Hop Family Tree series, this time chronicling the acts — from the Beastie Boys to one-hit wonders — that rose to the top in 1984 and 1985.

Jolenta Greenberg and Kristen Meinzer live by a new self-help book for each episode of their podcast By the Book, so they're experts on which ones might really help us keep our New Year's resolutions.

U.S. law prohibits people on Medicare from using the discount coupons the makers of expensive medicines offer. The law aims to reduce federal drug spending and Medicare fraud, but can feel unfair.